Burns J W & Co. Inc. NY Sells 1,837 Shares of CME Group Inc. (NASDAQ:CME)

Burns J W & Co. Inc. NY lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 12.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,023 shares of the financial services provider’s stock after selling 1,837 shares during the period. Burns J W & Co. Inc. NY’s holdings in CME Group were worth $2,874,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in CME. Salomon & Ludwin LLC acquired a new stake in CME Group during the first quarter worth approximately $28,000. Y.D. More Investments Ltd acquired a new stake in CME Group during the second quarter worth approximately $36,000. McClarren Financial Advisors Inc. grew its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares in the last quarter. Asset Dedication LLC grew its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares in the last quarter. Finally, Rise Advisors LLC acquired a new stake in CME Group during the first quarter worth approximately $41,000. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Up 0.1 %

NASDAQ CME traded up $0.16 on Friday, reaching $224.43. The company had a trading volume of 1,585,768 shares, compared to its average volume of 1,959,577. The firm has a market cap of $80.81 billion, a price-to-earnings ratio of 25.53, a P/E/G ratio of 8.74 and a beta of 0.55. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $226.78. The business has a 50 day moving average of $212.17 and a two-hundred day moving average of $207.75. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the business posted $2.30 earnings per share. Analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. CME Group’s payout ratio is currently 52.33%.

Analyst Upgrades and Downgrades

CME has been the subject of several recent analyst reports. Barclays upped their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Bank of America upped their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday. Piper Sandler restated an “overweight” rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Citigroup upped their target price on CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, TD Cowen initiated coverage on CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $213.77.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.